Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-06-11

AUTHORS

Sahba Fekri, Ramin Nourinia, Babak Rahimi-Ardabili, Arash Daneshtalab, Hamideh Sabbaghi, Hamid Ahmadieh, Bahareh Kheiri

ABSTRACT

BackgroundTo investigate the adjunctive effect of an intravitreal ROCK inhibitor (fasudil) in combination with intravitreal bevacizumab (IVB) on refractory macular edema secondary to retinal vein occlusion (RVO).MethodsIn this prospective interventional case series, 17 eyes of 17 patients (10 men, 7 women) with refractory RVO-related macular edema underwent three consecutive intravitreal injections of bevacizumab plus fasudil. Monthly evaluation was continued up to 12 months and IVB injection was performed if needed during the follow-up. Changes in the best corrected visual acuity (BCVA) was the primary outcome measure. The secondary outcome measures included central macular thickness (CMT) changes and any adverse events.ResultsBCVA significantly improved (mean change: −0.15 LogMAR; P = 0.017) after 3 consecutive intravitreal injections of fasudil in combination with bevacizumab. CMT significantly decreased (mean change: −206 µm; P = 0.028). The anatomical and functional improvement was maintained during the 12 month follow-up. No adverse effects were noticed.ConclusionIntravitreal ROCK inhibitors may break the resistance to anti-VEGF therapy and improve the RVO induced macular edema via affecting the VEGF-independent pathways. More... »

PAGES

37

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40942-022-00389-x

DOI

http://dx.doi.org/10.1186/s40942-022-00389-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1148594566

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35690809


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1113", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Ophthalmology and Optometry", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411600.2", 
          "name": [
            "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran", 
            "Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fekri", 
        "givenName": "Sahba", 
        "id": "sg:person.011055730637.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011055730637.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411600.2", 
          "name": [
            "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran", 
            "Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nourinia", 
        "givenName": "Ramin", 
        "id": "sg:person.01260160570.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260160570.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411600.2", 
          "name": [
            "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rahimi-Ardabili", 
        "givenName": "Babak", 
        "id": "sg:person.0733021617.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733021617.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411600.2", 
          "name": [
            "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Daneshtalab", 
        "givenName": "Arash", 
        "id": "sg:person.013521745413.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013521745413.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Optometry, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411600.2", 
          "name": [
            "Ophthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran", 
            "Department of Optometry, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sabbaghi", 
        "givenName": "Hamideh", 
        "id": "sg:person.01276614116.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276614116.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411600.2", 
          "name": [
            "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahmadieh", 
        "givenName": "Hamid", 
        "id": "sg:person.01223352765.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223352765.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411600.2", 
          "name": [
            "Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kheiri", 
        "givenName": "Bahareh", 
        "id": "sg:person.0756177554.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756177554.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00417-019-04283-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1112585913", 
          "https://doi.org/10.1007/s00417-019-04283-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10384-007-0471-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026342774", 
          "https://doi.org/10.1007/s10384-007-0471-0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-06-11", 
    "datePublishedReg": "2022-06-11", 
    "description": "BackgroundTo investigate the adjunctive effect of an intravitreal ROCK inhibitor (fasudil) in combination with intravitreal bevacizumab (IVB) on refractory macular edema secondary to retinal vein occlusion (RVO).MethodsIn this prospective interventional case series, 17 eyes of 17 patients (10 men, 7 women) with refractory RVO-related macular edema underwent three consecutive intravitreal injections of bevacizumab plus fasudil. Monthly evaluation was continued up to 12\u00a0months and IVB injection was performed if needed during the follow-up. Changes in the best corrected visual acuity (BCVA) was the primary outcome measure. The secondary outcome measures included central macular thickness (CMT) changes and any adverse events.ResultsBCVA significantly improved (mean change: \u22120.15 LogMAR; P\u2009=\u20090.017) after 3 consecutive intravitreal injections of fasudil in combination with bevacizumab. CMT significantly decreased (mean change: \u2212206\u00a0\u00b5m; P\u2009=\u20090.028). The anatomical and functional improvement was maintained during the 12\u00a0month follow-up. No adverse effects were noticed.ConclusionIntravitreal ROCK inhibitors may break the resistance to anti-VEGF therapy and improve the RVO induced macular edema via affecting the VEGF-independent pathways.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s40942-022-00389-x", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1053225", 
        "issn": [
          "2056-9920"
        ], 
        "name": "International Journal of Retina and Vitreous", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "retinal vein occlusion", 
      "refractory macular edema", 
      "consecutive intravitreal injections", 
      "macular edema", 
      "intravitreal injection", 
      "intravitreal bevacizumab", 
      "vein occlusion", 
      "outcome measures", 
      "prospective interventional case series", 
      "central macular thickness (CMT) changes", 
      "ROCK inhibitor", 
      "macular thickness changes", 
      "interventional case series", 
      "Secondary outcome measures", 
      "anti-VEGF therapy", 
      "primary outcome measure", 
      "VEGF-independent pathways", 
      "IVB injection", 
      "adverse events", 
      "case series", 
      "visual acuity", 
      "adjunctive effect", 
      "functional improvement", 
      "bevacizumab", 
      "edema", 
      "pilot study", 
      "adverse effects", 
      "injection", 
      "fasudil", 
      "inhibitors", 
      "occlusion", 
      "months", 
      "monthly evaluations", 
      "ResultsBCVA", 
      "patients", 
      "BackgroundTo", 
      "acuity", 
      "therapy", 
      "MethodsIn", 
      "thickness changes", 
      "eyes", 
      "measures", 
      "CMT", 
      "effect", 
      "changes", 
      "pathway", 
      "combination", 
      "evaluation", 
      "study", 
      "events", 
      "improvement", 
      "resistance", 
      "series"
    ], 
    "name": "Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study", 
    "pagination": "37", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1148594566"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40942-022-00389-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35690809"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40942-022-00389-x", 
      "https://app.dimensions.ai/details/publication/pub.1148594566"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_956.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s40942-022-00389-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40942-022-00389-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40942-022-00389-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40942-022-00389-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40942-022-00389-x'


 

This table displays all metadata directly associated to this object as RDF triples.

168 TRIPLES      21 PREDICATES      80 URIs      70 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40942-022-00389-x schema:about anzsrc-for:11
2 anzsrc-for:1113
3 schema:author N0d9f44448ef74223ba60084d1cc677ca
4 schema:citation sg:pub.10.1007/s00417-019-04283-5
5 sg:pub.10.1007/s10384-007-0471-0
6 schema:datePublished 2022-06-11
7 schema:datePublishedReg 2022-06-11
8 schema:description BackgroundTo investigate the adjunctive effect of an intravitreal ROCK inhibitor (fasudil) in combination with intravitreal bevacizumab (IVB) on refractory macular edema secondary to retinal vein occlusion (RVO).MethodsIn this prospective interventional case series, 17 eyes of 17 patients (10 men, 7 women) with refractory RVO-related macular edema underwent three consecutive intravitreal injections of bevacizumab plus fasudil. Monthly evaluation was continued up to 12 months and IVB injection was performed if needed during the follow-up. Changes in the best corrected visual acuity (BCVA) was the primary outcome measure. The secondary outcome measures included central macular thickness (CMT) changes and any adverse events.ResultsBCVA significantly improved (mean change: −0.15 LogMAR; P = 0.017) after 3 consecutive intravitreal injections of fasudil in combination with bevacizumab. CMT significantly decreased (mean change: −206 µm; P = 0.028). The anatomical and functional improvement was maintained during the 12 month follow-up. No adverse effects were noticed.ConclusionIntravitreal ROCK inhibitors may break the resistance to anti-VEGF therapy and improve the RVO induced macular edema via affecting the VEGF-independent pathways.
9 schema:genre article
10 schema:isAccessibleForFree true
11 schema:isPartOf N4504bc8c92ac42d58170adad36b7de1a
12 Nd699a98100d3419ab0bf3e72c9ddc854
13 sg:journal.1053225
14 schema:keywords BackgroundTo
15 CMT
16 IVB injection
17 MethodsIn
18 ROCK inhibitor
19 ResultsBCVA
20 Secondary outcome measures
21 VEGF-independent pathways
22 acuity
23 adjunctive effect
24 adverse effects
25 adverse events
26 anti-VEGF therapy
27 bevacizumab
28 case series
29 central macular thickness (CMT) changes
30 changes
31 combination
32 consecutive intravitreal injections
33 edema
34 effect
35 evaluation
36 events
37 eyes
38 fasudil
39 functional improvement
40 improvement
41 inhibitors
42 injection
43 interventional case series
44 intravitreal bevacizumab
45 intravitreal injection
46 macular edema
47 macular thickness changes
48 measures
49 monthly evaluations
50 months
51 occlusion
52 outcome measures
53 pathway
54 patients
55 pilot study
56 primary outcome measure
57 prospective interventional case series
58 refractory macular edema
59 resistance
60 retinal vein occlusion
61 series
62 study
63 therapy
64 thickness changes
65 vein occlusion
66 visual acuity
67 schema:name Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study
68 schema:pagination 37
69 schema:productId N0a13678ea6d7445282be7f2f11b888ab
70 Nefba9f52829d4a2fab715f457040df5b
71 Nf2aece2d924a4510b8e23a40cbee62a0
72 schema:sameAs https://app.dimensions.ai/details/publication/pub.1148594566
73 https://doi.org/10.1186/s40942-022-00389-x
74 schema:sdDatePublished 2022-12-01T06:44
75 schema:sdLicense https://scigraph.springernature.com/explorer/license/
76 schema:sdPublisher N2278eda3d16e407bad392d3c242d7c26
77 schema:url https://doi.org/10.1186/s40942-022-00389-x
78 sgo:license sg:explorer/license/
79 sgo:sdDataset articles
80 rdf:type schema:ScholarlyArticle
81 N0a13678ea6d7445282be7f2f11b888ab schema:name dimensions_id
82 schema:value pub.1148594566
83 rdf:type schema:PropertyValue
84 N0c2eab40d6b64c7399b1934a3f266c21 rdf:first sg:person.01276614116.56
85 rdf:rest N4ffdebbe10a142ddae5c2ba7034051e1
86 N0c9cc87508d049a0957ce30b4cd68d66 rdf:first sg:person.013521745413.20
87 rdf:rest N0c2eab40d6b64c7399b1934a3f266c21
88 N0d9f44448ef74223ba60084d1cc677ca rdf:first sg:person.011055730637.51
89 rdf:rest Nacf7b86a9488437caa12fcec395dd22c
90 N2278eda3d16e407bad392d3c242d7c26 schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 N4504bc8c92ac42d58170adad36b7de1a schema:volumeNumber 8
93 rdf:type schema:PublicationVolume
94 N4ffdebbe10a142ddae5c2ba7034051e1 rdf:first sg:person.01223352765.78
95 rdf:rest Nca5be3bc944b4e6bbacbcd9771e05670
96 N6d72ae3acac742fb9154eef124633af5 rdf:first sg:person.0733021617.53
97 rdf:rest N0c9cc87508d049a0957ce30b4cd68d66
98 Nacf7b86a9488437caa12fcec395dd22c rdf:first sg:person.01260160570.99
99 rdf:rest N6d72ae3acac742fb9154eef124633af5
100 Nca5be3bc944b4e6bbacbcd9771e05670 rdf:first sg:person.0756177554.74
101 rdf:rest rdf:nil
102 Nd699a98100d3419ab0bf3e72c9ddc854 schema:issueNumber 1
103 rdf:type schema:PublicationIssue
104 Nefba9f52829d4a2fab715f457040df5b schema:name doi
105 schema:value 10.1186/s40942-022-00389-x
106 rdf:type schema:PropertyValue
107 Nf2aece2d924a4510b8e23a40cbee62a0 schema:name pubmed_id
108 schema:value 35690809
109 rdf:type schema:PropertyValue
110 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
111 schema:name Medical and Health Sciences
112 rdf:type schema:DefinedTerm
113 anzsrc-for:1113 schema:inDefinedTermSet anzsrc-for:
114 schema:name Ophthalmology and Optometry
115 rdf:type schema:DefinedTerm
116 sg:journal.1053225 schema:issn 2056-9920
117 schema:name International Journal of Retina and Vitreous
118 schema:publisher Springer Nature
119 rdf:type schema:Periodical
120 sg:person.011055730637.51 schema:affiliation grid-institutes:grid.411600.2
121 schema:familyName Fekri
122 schema:givenName Sahba
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011055730637.51
124 rdf:type schema:Person
125 sg:person.01223352765.78 schema:affiliation grid-institutes:grid.411600.2
126 schema:familyName Ahmadieh
127 schema:givenName Hamid
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223352765.78
129 rdf:type schema:Person
130 sg:person.01260160570.99 schema:affiliation grid-institutes:grid.411600.2
131 schema:familyName Nourinia
132 schema:givenName Ramin
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260160570.99
134 rdf:type schema:Person
135 sg:person.01276614116.56 schema:affiliation grid-institutes:grid.411600.2
136 schema:familyName Sabbaghi
137 schema:givenName Hamideh
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276614116.56
139 rdf:type schema:Person
140 sg:person.013521745413.20 schema:affiliation grid-institutes:grid.411600.2
141 schema:familyName Daneshtalab
142 schema:givenName Arash
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013521745413.20
144 rdf:type schema:Person
145 sg:person.0733021617.53 schema:affiliation grid-institutes:grid.411600.2
146 schema:familyName Rahimi-Ardabili
147 schema:givenName Babak
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733021617.53
149 rdf:type schema:Person
150 sg:person.0756177554.74 schema:affiliation grid-institutes:grid.411600.2
151 schema:familyName Kheiri
152 schema:givenName Bahareh
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756177554.74
154 rdf:type schema:Person
155 sg:pub.10.1007/s00417-019-04283-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112585913
156 https://doi.org/10.1007/s00417-019-04283-5
157 rdf:type schema:CreativeWork
158 sg:pub.10.1007/s10384-007-0471-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026342774
159 https://doi.org/10.1007/s10384-007-0471-0
160 rdf:type schema:CreativeWork
161 grid-institutes:grid.411600.2 schema:alternateName Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
162 Department of Optometry, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran
163 Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran
164 schema:name Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
165 Department of Optometry, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran
166 Ophthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
167 Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St., Pasdaran Ave, 16666, Tehran, Iran
168 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...